Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 799,159 | 693,420 | 631,477 | 628,371 | 867,257 |
| Marketable Securities | 124,210 | 126,393 | 132,875 | 189,213 | 156,812 |
| Receivables | 266,865 | 283,315 | 289,597 | 243,593 | 236,229 |
| Inventories | 32,398 | 30,353 | 26,111 | 23,549 | 24,096 |
| Other current assets | 192,585 | 275,262 | 215,923 | 176,093 | 170,402 |
| TOTAL | $1,469,365 | $1,462,596 | $1,349,415 | $1,310,894 | $1,504,719 |
| Non-Current Assets | |||||
| PPE Net | 501,666 | 508,021 | 512,168 | 513,481 | 517,870 |
| Investments And Advances | 98,103 | 100,797 | 124,024 | 102,514 | 106,726 |
| Intangibles | 603,641 | 469,010 | 475,297 | 477,412 | 487,533 |
| Other Non-Current Assets | 335,163 | 295,709 | 287,619 | 285,247 | 303,088 |
| TOTAL | $1,538,573 | $1,373,537 | $1,399,108 | $1,378,654 | $1,415,217 |
| Total Assets | $3,007,938 | $2,836,133 | $2,748,523 | $2,689,548 | $2,919,936 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,395 | 17,170 | 17,361 | 14,171 | 16,821 |
| Accrued Expenses | 346,525 | 246,757 | 230,346 | 230,237 | 229,267 |
| Other current liabilities | 36,586 | 22,963 | 22,356 | 18,588 | 21,216 |
| TOTAL | $423,036 | $314,011 | $290,447 | $277,518 | $285,485 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 202,173 | 165,943 | 165,478 | 161,007 | 174,913 |
| TOTAL | $202,179 | $166,130 | $165,551 | $161,010 | $174,926 |
| Total Liabilities | $625,215 | $480,141 | $455,998 | $438,528 | $460,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,641 | 95,506 | 95,822 | 95,958 | 97,677 |
| Common Shares | 94 | 95 | 95 | 94 | 98 |
| Retained earnings | 2,397,307 | 2,378,115 | 2,319,358 | 2,297,730 | 2,484,689 |
| Other shareholders' equity | -14,678 | -22,218 | -26,928 | -46,804 | -25,262 |
| TOTAL | $2,382,723 | $2,355,992 | $2,292,525 | $2,251,020 | $2,459,525 |
| Total Liabilities And Equity | $3,007,938 | $2,836,133 | $2,748,523 | $2,689,548 | $2,919,936 |